カテゴリ： LP Information, 世界, 医療/バイオ

VEGFA 抗体の世界市場2022-2028：モノクローナル抗体、ポリクローナル抗体

■ 英語タイトル：Global VEGFA Antibody Market Growth 2022-2028

調査会社LP Information社が発行したリサーチレポート（データ管理コード：LP22DC5060）■ 発行会社/調査会社：LP Information
■ 商品コード：LP22DC5060
■ 発行日：2022年12月
■ 調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
■ 産業分野：医薬品
■ ページ数：114
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※LP Information社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[VEGFA 抗体の世界市場2022-2028：モノクローナル抗体、ポリクローナル抗体]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

VEGFA 抗体のグローバル市場規模は、2021年のxxx百万ドルから2028年までにxxx百万ドルに増加すると推定されており、2022年～2028年の年平均成長率（CAGR）はxx%を示しています。COVID-19とロシア・ウクライナ戦争の不確実性を念頭に置いて、さまざまな最終用途部門に対するパンデミックの直接的および間接的な影響を継続的に追跡・分析しています。これらのインサイトは、主要な市場要因としてレポートに含まれています。
VEGFA 抗体のアジア太平洋市場は、2022年にxxx百万ドルの市場規模が見込まれ、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。VEGFA 抗体の米国市場は、2022年にxxx百万ドルの規模があり、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。VEGFA 抗体のヨーロッパ市場は、2022年にxxx百万ドルの規模が見込まれ、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。VEGFA 抗体の中国市場は、2022年にxxx百万ドルの規模があり、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。

世界の主要なVEGFA 抗体関連企業としては、Sino Biological, Inc.、 ​​Abcam、 Thermo Fisher Scientific (China) Co., Ltd.、 Bio-Techne、 BioLegend、 LifeSpan BioSciences, Inc、 Elabscience Biotechnology Inc.、 Boster Biological Technology、 Merck、 Wuhan Fine Biotech Co., Ltd.、 ProSci Incorporated、 Abbexa、 Miltenyi Biotec、 Arigo Biolaboratories Corp.、 Assay Genieなどをカバーしています。売上の面では世界最大の2社が2021年にほぼxx%の市場シェアを占めています。

*** レポート範囲 ***

この最新のレポートはすべての重要な側面をカバーしながらVEGFA 抗体のグローバル市場に関する深いインサイトを提供します。これは、市場のマクロな概要から、市場規模、競争環境、開発動向、ニッチ市場、主要な市場ドライバーと課題、バリュー チェーン分析などのミクロの詳細にまで及びます。当レポートは読者がパンデミックおよびロシア・ウクライナ戦争中に世界中でVEGFA 抗体市場シナリオがどのように変化したかを理解できるように定量的データと定性的データの両方を使用して、VEGFA 抗体のグローバル市場の全体像を提供することを目的としています。

分析の対象となる基準年は2021年で、市場の予測は2022年～2028年までのものです。

*** 市場セグメンテーション ***

この調査ではVEGFA 抗体市場を細分化し、種類別 (モノクローナル抗体、ポリクローナル抗体)、用途別 (フローサイトメトリー、ELISA、ウエスタンブロット、免疫沈降、免疫蛍光、その他)、および地域別 (アジア太平洋、アメリカ州、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：モノクローナル抗体、ポリクローナル抗体

・用途別区分：フローサイトメトリー、ELISA、ウエスタンブロット、免疫沈降、免疫蛍光、その他

・地域別区分
アメリカ州（アメリカ、カナダ、メキシコ、ブラジル）
APAC/アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

*** 各章の紹介 ***
第1章：VEGFA 抗体の範囲、調査方法など
第2章：エグゼクティブサマリー、世界のVEGFA 抗体市場規模 (販売量、売上) およびCAGR、地域別・種類別・用途別、2017年～2022年までの推移データ、および2028年までの市場予測
第3章：企業別VEGFA 抗体の販売量、売上、平均価格、グローバル市場シェア、および業界ランキング
第4章：地域別および国別のVEGFA 抗体の販売量と売上（米国、カナダ、ヨーロッパ、中国、日本、韓国、東南アジア、インド、ラテンアメリカ、中東・アフリカなど）
第5/6/7/8章：アメリカ州、アジア太平洋、ヨーロッパ、中東・アフリカの国別、種類別の販売セグメント
第9章：市場動向、市場予測、機会、将来の市場に影響を与える経済動向の分析
第10章：製造コスト構造分析
第11章：販売チャンネル、販売業者および顧客
第12章：地域別、国別、種類別、用途別の世界のVEGFA 抗体市場規模予測
第13章：主要企業の包括的な企業プロファイル
第14章：調査の結果

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：VEGFA 抗体の年間販売量2017-2028、地域別現状・将来分析
・VEGFA 抗体の種類別セグメント：モノクローナル抗体、ポリクローナル抗体
・VEGFA 抗体の種類別販売量：2017-2022年の販売量、売上、市場シェア、販売価格
・VEGFA 抗体の用途別セグメント：フローサイトメトリー、ELISA、ウエスタンブロット、免疫沈降、免疫蛍光、その他
・VEGFA 抗体の用途別販売量：2017-2022年の販売量、売上、市場シェア、販売価格

企業別世界のVEGFA 抗体市場
・企業別のグローバルVEGFA 抗体市場データ：2020-2022年の年間販売量、市場シェア
・企業別のVEGFA 抗体の年間売上：2020-2022年の売上、市場シェア
・企業別のVEGFA 抗体販売価格
・主要企業のVEGFA 抗体生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

VEGFA 抗体の地域別レビュー
・地域別のVEGFA 抗体市場規模2017-2022：年間販売量、売上
・主要国別のVEGFA 抗体市場規模2017-2022：年間販売量、売上
・アメリカ州のVEGFA 抗体販売の成長
・アジア太平洋のVEGFA 抗体販売の成長
・ヨーロッパのVEGFA 抗体販売の成長
・中東・アフリカのVEGFA 抗体販売の成長

アメリカ州市場
・アメリカ州の国別のVEGFA 抗体販売量、売上（2017-2022）
・アメリカ州のVEGFA 抗体の種類別販売量
・アメリカ州のVEGFA 抗体の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋（APAC）市場
・アジア太平洋の国別のVEGFA 抗体販売量、売上（2017-2022）
・アジア太平洋のVEGFA 抗体の種類別販売量
・アジア太平洋のVEGFA 抗体の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のVEGFA 抗体販売量、売上（2017-2022）
・ヨーロッパのVEGFA 抗体の種類別販売量
・ヨーロッパのVEGFA 抗体の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のVEGFA 抗体販売量、売上（2017-2022）
・中東・アフリカのVEGFA 抗体の種類別販売量
・中東・アフリカのVEGFA 抗体の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・VEGFA 抗体の製造コスト構造分析
・VEGFA 抗体の製造プロセス分析
・VEGFA 抗体の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・VEGFA 抗体の主要なグローバル販売業者
・VEGFA 抗体の主要なグローバル顧客

地域別のVEGFA 抗体市場予測レビュー
・地域別のVEGFA 抗体市場規模予測（2023-2028）
・アメリカ州の国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・VEGFA 抗体の種類別市場規模予測
・VEGFA 抗体の用途別市場規模予測

主要企業分析
Sino Biological, Inc.、 ​​Abcam、 Thermo Fisher Scientific (China) Co., Ltd.、 Bio-Techne、 BioLegend、 LifeSpan BioSciences, Inc、 Elabscience Biotechnology Inc.、 Boster Biological Technology、 Merck、 Wuhan Fine Biotech Co., Ltd.、 ProSci Incorporated、 Abbexa、 Miltenyi Biotec、 Arigo Biolaboratories Corp.、 Assay Genie
・企業情報
・VEGFA 抗体製品
・VEGFA 抗体販売量、売上、価格、粗利益（2020-2022）
・主要ビジネス概要
・最新動向

調査の結果

VEGFA Antibody is an unconjugated antibody to VEGFA.
The global market for VEGFA Antibody is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC VEGFA Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States VEGFA Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe VEGFA Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China VEGFA Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key VEGFA Antibody players cover Sino Biological, Inc., ​​Abcam, Thermo Fisher Scientific (China) Co., Ltd., Bio-Techne and BioLegend, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

[Report Coverage]
This latest report provides a deep insight into the global VEGFA Antibody market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global VEGFA Antibody market, with both quantitative and qualitative data, to help readers understand how the VEGFA Antibody market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

[Market Segmentation]
The study segments the VEGFA Antibody market and forecasts the market size by Type (Monoclonal Antibody and Polyclonal Antibody,), by Application (Flow Cytometry, ELISA, Western Blot and Immunoprecipitation), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Monoclonal Antibody
Polyclonal Antibody
Segmentation by application
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Sino Biological, Inc.
​​Abcam
Thermo Fisher Scientific (China) Co., Ltd.
Bio-Techne
BioLegend
LifeSpan BioSciences, Inc
Elabscience Biotechnology Inc.
Boster Biological Technology
Merck
Wuhan Fine Biotech Co., Ltd.
ProSci Incorporated
Abbexa
Miltenyi Biotec
Arigo Biolaboratories Corp.
Assay Genie

[Chapter Introduction]
Chapter 1: Scope of VEGFA Antibody, Research Methodology, etc.
Chapter 2: Executive Summary, global VEGFA Antibody market size (sales and revenue) and CAGR, VEGFA Antibody market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: VEGFA Antibody sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global VEGFA Antibody sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global VEGFA Antibody market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Sino Biological, Inc., ​​Abcam, Thermo Fisher Scientific (China) Co., Ltd., Bio-Techne, BioLegend, LifeSpan BioSciences, Inc, Elabscience Biotechnology Inc., Boster Biological Technology and Merck, etc.
Chapter 14: Research Findings and Conclusion

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global VEGFA Antibody Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for VEGFA Antibody by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for VEGFA Antibody by Country/Region, 2017, 2022 & 2028
2.2 VEGFA Antibody Segment by Type
2.2.1 Monoclonal Antibody
2.2.2 Polyclonal Antibody
2.3 VEGFA Antibody Sales by Type
2.3.1 Global VEGFA Antibody Sales Market Share by Type (2017-2022)
2.3.2 Global VEGFA Antibody Revenue and Market Share by Type (2017-2022)
2.3.3 Global VEGFA Antibody Sale Price by Type (2017-2022)
2.4 VEGFA Antibody Segment by Application
2.4.1 Flow Cytometry
2.4.2 ELISA
2.4.3 Western Blot
2.4.4 Immunoprecipitation
2.4.5 Immunofluorescence
2.4.6 Other
2.5 VEGFA Antibody Sales by Application
2.5.1 Global VEGFA Antibody Sale Market Share by Application (2017-2022)
2.5.2 Global VEGFA Antibody Revenue and Market Share by Application (2017-2022)
2.5.3 Global VEGFA Antibody Sale Price by Application (2017-2022)
3 Global VEGFA Antibody by Company
3.1 Global VEGFA Antibody Breakdown Data by Company
3.1.1 Global VEGFA Antibody Annual Sales by Company (2020-2022)
3.1.2 Global VEGFA Antibody Sales Market Share by Company (2020-2022)
3.2 Global VEGFA Antibody Annual Revenue by Company (2020-2022)
3.2.1 Global VEGFA Antibody Revenue by Company (2020-2022)
3.2.2 Global VEGFA Antibody Revenue Market Share by Company (2020-2022)
3.3 Global VEGFA Antibody Sale Price by Company
3.4 Key Manufacturers VEGFA Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers VEGFA Antibody Product Location Distribution
3.4.2 Players VEGFA Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for VEGFA Antibody by Geographic Region
4.1 World Historic VEGFA Antibody Market Size by Geographic Region (2017-2022)
4.1.1 Global VEGFA Antibody Annual Sales by Geographic Region (2017-2022)
4.1.2 Global VEGFA Antibody Annual Revenue by Geographic Region
4.2 World Historic VEGFA Antibody Market Size by Country/Region (2017-2022)
4.2.1 Global VEGFA Antibody Annual Sales by Country/Region (2017-2022)
4.2.2 Global VEGFA Antibody Annual Revenue by Country/Region
4.3 Americas VEGFA Antibody Sales Growth
4.4 APAC VEGFA Antibody Sales Growth
4.5 Europe VEGFA Antibody Sales Growth
4.6 Middle East & Africa VEGFA Antibody Sales Growth
5 Americas
5.1 Americas VEGFA Antibody Sales by Country
5.1.1 Americas VEGFA Antibody Sales by Country (2017-2022)
5.1.2 Americas VEGFA Antibody Revenue by Country (2017-2022)
5.2 Americas VEGFA Antibody Sales by Type
5.3 Americas VEGFA Antibody Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC VEGFA Antibody Sales by Region
6.1.1 APAC VEGFA Antibody Sales by Region (2017-2022)
6.1.2 APAC VEGFA Antibody Revenue by Region (2017-2022)
6.2 APAC VEGFA Antibody Sales by Type
6.3 APAC VEGFA Antibody Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe VEGFA Antibody by Country
7.1.1 Europe VEGFA Antibody Sales by Country (2017-2022)
7.1.2 Europe VEGFA Antibody Revenue by Country (2017-2022)
7.2 Europe VEGFA Antibody Sales by Type
7.3 Europe VEGFA Antibody Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa VEGFA Antibody by Country
8.1.1 Middle East & Africa VEGFA Antibody Sales by Country (2017-2022)
8.1.2 Middle East & Africa VEGFA Antibody Revenue by Country (2017-2022)
8.2 Middle East & Africa VEGFA Antibody Sales by Type
8.3 Middle East & Africa VEGFA Antibody Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of VEGFA Antibody
10.3 Manufacturing Process Analysis of VEGFA Antibody
10.4 Industry Chain Structure of VEGFA Antibody
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 VEGFA Antibody Distributors
11.3 VEGFA Antibody Customer
12 World Forecast Review for VEGFA Antibody by Geographic Region
12.1 Global VEGFA Antibody Market Size Forecast by Region
12.1.1 Global VEGFA Antibody Forecast by Region (2023-2028)
12.1.2 Global VEGFA Antibody Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global VEGFA Antibody Forecast by Type
12.7 Global VEGFA Antibody Forecast by Application
13 Key Players Analysis
13.1 Sino Biological, Inc.
13.1.1 Sino Biological, Inc. Company Information
13.1.2 Sino Biological, Inc. VEGFA Antibody Product Offered
13.1.3 Sino Biological, Inc. VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sino Biological, Inc. Main Business Overview
13.1.5 Sino Biological, Inc. Latest Developments
13.2 ​​Abcam
13.2.1 ​​Abcam Company Information
13.2.2 ​​Abcam VEGFA Antibody Product Offered
13.2.3 ​​Abcam VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 ​​Abcam Main Business Overview
13.2.5 ​​Abcam Latest Developments
13.3 Thermo Fisher Scientific (China) Co., Ltd.
13.3.1 Thermo Fisher Scientific (China) Co., Ltd. Company Information
13.3.2 Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Product Offered
13.3.3 Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Thermo Fisher Scientific (China) Co., Ltd. Main Business Overview
13.3.5 Thermo Fisher Scientific (China) Co., Ltd. Latest Developments
13.4 Bio-Techne
13.4.1 Bio-Techne Company Information
13.4.2 Bio-Techne VEGFA Antibody Product Offered
13.4.3 Bio-Techne VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bio-Techne Main Business Overview
13.4.5 Bio-Techne Latest Developments
13.5 BioLegend
13.5.1 BioLegend Company Information
13.5.2 BioLegend VEGFA Antibody Product Offered
13.5.3 BioLegend VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 BioLegend Main Business Overview
13.5.5 BioLegend Latest Developments
13.6 LifeSpan BioSciences, Inc
13.6.1 LifeSpan BioSciences, Inc Company Information
13.6.2 LifeSpan BioSciences, Inc VEGFA Antibody Product Offered
13.6.3 LifeSpan BioSciences, Inc VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 LifeSpan BioSciences, Inc Main Business Overview
13.6.5 LifeSpan BioSciences, Inc Latest Developments
13.7 Elabscience Biotechnology Inc.
13.7.1 Elabscience Biotechnology Inc. Company Information
13.7.2 Elabscience Biotechnology Inc. VEGFA Antibody Product Offered
13.7.3 Elabscience Biotechnology Inc. VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Elabscience Biotechnology Inc. Main Business Overview
13.7.5 Elabscience Biotechnology Inc. Latest Developments
13.8 Boster Biological Technology
13.8.1 Boster Biological Technology Company Information
13.8.2 Boster Biological Technology VEGFA Antibody Product Offered
13.8.3 Boster Biological Technology VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Boster Biological Technology Main Business Overview
13.8.5 Boster Biological Technology Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck VEGFA Antibody Product Offered
13.9.3 Merck VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Wuhan Fine Biotech Co., Ltd.
13.10.1 Wuhan Fine Biotech Co., Ltd. Company Information
13.10.2 Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Product Offered
13.10.3 Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Wuhan Fine Biotech Co., Ltd. Main Business Overview
13.10.5 Wuhan Fine Biotech Co., Ltd. Latest Developments
13.11 ProSci Incorporated
13.11.1 ProSci Incorporated Company Information
13.11.2 ProSci Incorporated VEGFA Antibody Product Offered
13.11.3 ProSci Incorporated VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 ProSci Incorporated Main Business Overview
13.11.5 ProSci Incorporated Latest Developments
13.12 Abbexa
13.12.1 Abbexa Company Information
13.12.2 Abbexa VEGFA Antibody Product Offered
13.12.3 Abbexa VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Abbexa Main Business Overview
13.12.5 Abbexa Latest Developments
13.13 Miltenyi Biotec
13.13.1 Miltenyi Biotec Company Information
13.13.2 Miltenyi Biotec VEGFA Antibody Product Offered
13.13.3 Miltenyi Biotec VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Miltenyi Biotec Main Business Overview
13.13.5 Miltenyi Biotec Latest Developments
13.14 Arigo Biolaboratories Corp.
13.14.1 Arigo Biolaboratories Corp. Company Information
13.14.2 Arigo Biolaboratories Corp. VEGFA Antibody Product Offered
13.14.3 Arigo Biolaboratories Corp. VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Arigo Biolaboratories Corp. Main Business Overview
13.14.5 Arigo Biolaboratories Corp. Latest Developments
13.15 Assay Genie
13.15.1 Assay Genie Company Information
13.15.2 Assay Genie VEGFA Antibody Product Offered
13.15.3 Assay Genie VEGFA Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Assay Genie Main Business Overview
13.15.5 Assay Genie Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. VEGFA Antibody Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. VEGFA Antibody Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Monoclonal Antibody
Table 4. Major Players of Polyclonal Antibody
Table 5. Global VEGFA Antibody Sales by Type (2017-2022) & (K Units)
Table 6. Global VEGFA Antibody Sales Market Share by Type (2017-2022)
Table 7. Global VEGFA Antibody Revenue by Type (2017-2022) & ($ million)
Table 8. Global VEGFA Antibody Revenue Market Share by Type (2017-2022)
Table 9. Global VEGFA Antibody Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global VEGFA Antibody Sales by Application (2017-2022) & (K Units)
Table 11. Global VEGFA Antibody Sales Market Share by Application (2017-2022)
Table 12. Global VEGFA Antibody Revenue by Application (2017-2022)
Table 13. Global VEGFA Antibody Revenue Market Share by Application (2017-2022)
Table 14. Global VEGFA Antibody Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global VEGFA Antibody Sales by Company (2020-2022) & (K Units)
Table 16. Global VEGFA Antibody Sales Market Share by Company (2020-2022)
Table 17. Global VEGFA Antibody Revenue by Company (2020-2022) ($ Millions)
Table 18. Global VEGFA Antibody Revenue Market Share by Company (2020-2022)
Table 19. Global VEGFA Antibody Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers VEGFA Antibody Producing Area Distribution and Sales Area
Table 21. Players VEGFA Antibody Products Offered
Table 22. VEGFA Antibody Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global VEGFA Antibody Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global VEGFA Antibody Sales Market Share Geographic Region (2017-2022)
Table 27. Global VEGFA Antibody Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global VEGFA Antibody Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global VEGFA Antibody Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global VEGFA Antibody Sales Market Share by Country/Region (2017-2022)
Table 31. Global VEGFA Antibody Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global VEGFA Antibody Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas VEGFA Antibody Sales by Country (2017-2022) & (K Units)
Table 34. Americas VEGFA Antibody Sales Market Share by Country (2017-2022)
Table 35. Americas VEGFA Antibody Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas VEGFA Antibody Revenue Market Share by Country (2017-2022)
Table 37. Americas VEGFA Antibody Sales by Type (2017-2022) & (K Units)
Table 38. Americas VEGFA Antibody Sales Market Share by Type (2017-2022)
Table 39. Americas VEGFA Antibody Sales by Application (2017-2022) & (K Units)
Table 40. Americas VEGFA Antibody Sales Market Share by Application (2017-2022)
Table 41. APAC VEGFA Antibody Sales by Region (2017-2022) & (K Units)
Table 42. APAC VEGFA Antibody Sales Market Share by Region (2017-2022)
Table 43. APAC VEGFA Antibody Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC VEGFA Antibody Revenue Market Share by Region (2017-2022)
Table 45. APAC VEGFA Antibody Sales by Type (2017-2022) & (K Units)
Table 46. APAC VEGFA Antibody Sales Market Share by Type (2017-2022)
Table 47. APAC VEGFA Antibody Sales by Application (2017-2022) & (K Units)
Table 48. APAC VEGFA Antibody Sales Market Share by Application (2017-2022)
Table 49. Europe VEGFA Antibody Sales by Country (2017-2022) & (K Units)
Table 50. Europe VEGFA Antibody Sales Market Share by Country (2017-2022)
Table 51. Europe VEGFA Antibody Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe VEGFA Antibody Revenue Market Share by Country (2017-2022)
Table 53. Europe VEGFA Antibody Sales by Type (2017-2022) & (K Units)
Table 54. Europe VEGFA Antibody Sales Market Share by Type (2017-2022)
Table 55. Europe VEGFA Antibody Sales by Application (2017-2022) & (K Units)
Table 56. Europe VEGFA Antibody Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa VEGFA Antibody Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa VEGFA Antibody Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa VEGFA Antibody Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa VEGFA Antibody Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa VEGFA Antibody Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa VEGFA Antibody Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa VEGFA Antibody Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa VEGFA Antibody Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of VEGFA Antibody
Table 66. Key Market Challenges & Risks of VEGFA Antibody
Table 67. Key Industry Trends of VEGFA Antibody
Table 68. VEGFA Antibody Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. VEGFA Antibody Distributors List
Table 71. VEGFA Antibody Customer List
Table 72. Global VEGFA Antibody Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global VEGFA Antibody Sales Market Forecast by Region
Table 74. Global VEGFA Antibody Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global VEGFA Antibody Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas VEGFA Antibody Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas VEGFA Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC VEGFA Antibody Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC VEGFA Antibody Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe VEGFA Antibody Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe VEGFA Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa VEGFA Antibody Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa VEGFA Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global VEGFA Antibody Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global VEGFA Antibody Sales Market Share Forecast by Type (2023-2028)
Table 86. Global VEGFA Antibody Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global VEGFA Antibody Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global VEGFA Antibody Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global VEGFA Antibody Sales Market Share Forecast by Application (2023-2028)
Table 90. Global VEGFA Antibody Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global VEGFA Antibody Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sino Biological, Inc. Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 93. Sino Biological, Inc. VEGFA Antibody Product Offered
Table 94. Sino Biological, Inc. VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Sino Biological, Inc. Main Business
Table 96. Sino Biological, Inc. Latest Developments
Table 97. ​​Abcam Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 98. ​​Abcam VEGFA Antibody Product Offered
Table 99. ​​Abcam VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. ​​Abcam Main Business
Table 101. ​​Abcam Latest Developments
Table 102. Thermo Fisher Scientific (China) Co., Ltd. Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 103. Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Product Offered
Table 104. Thermo Fisher Scientific (China) Co., Ltd. VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Thermo Fisher Scientific (China) Co., Ltd. Main Business
Table 106. Thermo Fisher Scientific (China) Co., Ltd. Latest Developments
Table 107. Bio-Techne Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 108. Bio-Techne VEGFA Antibody Product Offered
Table 109. Bio-Techne VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Bio-Techne Main Business
Table 111. Bio-Techne Latest Developments
Table 112. BioLegend Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 113. BioLegend VEGFA Antibody Product Offered
Table 114. BioLegend VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. BioLegend Main Business
Table 116. BioLegend Latest Developments
Table 117. LifeSpan BioSciences, Inc Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 118. LifeSpan BioSciences, Inc VEGFA Antibody Product Offered
Table 119. LifeSpan BioSciences, Inc VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. LifeSpan BioSciences, Inc Main Business
Table 121. LifeSpan BioSciences, Inc Latest Developments
Table 122. Elabscience Biotechnology Inc. Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 123. Elabscience Biotechnology Inc. VEGFA Antibody Product Offered
Table 124. Elabscience Biotechnology Inc. VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Elabscience Biotechnology Inc. Main Business
Table 126. Elabscience Biotechnology Inc. Latest Developments
Table 127. Boster Biological Technology Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 128. Boster Biological Technology VEGFA Antibody Product Offered
Table 129. Boster Biological Technology VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Boster Biological Technology Main Business
Table 131. Boster Biological Technology Latest Developments
Table 132. Merck Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 133. Merck VEGFA Antibody Product Offered
Table 134. Merck VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Merck Main Business
Table 136. Merck Latest Developments
Table 137. Wuhan Fine Biotech Co., Ltd. Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 138. Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Product Offered
Table 139. Wuhan Fine Biotech Co., Ltd. VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Wuhan Fine Biotech Co., Ltd. Main Business
Table 141. Wuhan Fine Biotech Co., Ltd. Latest Developments
Table 142. ProSci Incorporated Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 143. ProSci Incorporated VEGFA Antibody Product Offered
Table 144. ProSci Incorporated VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. ProSci Incorporated Main Business
Table 146. ProSci Incorporated Latest Developments
Table 147. Abbexa Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 148. Abbexa VEGFA Antibody Product Offered
Table 149. Abbexa VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Abbexa Main Business
Table 151. Abbexa Latest Developments
Table 152. Miltenyi Biotec Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 153. Miltenyi Biotec VEGFA Antibody Product Offered
Table 154. Miltenyi Biotec VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Miltenyi Biotec Main Business
Table 156. Miltenyi Biotec Latest Developments
Table 157. Arigo Biolaboratories Corp. Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 158. Arigo Biolaboratories Corp. VEGFA Antibody Product Offered
Table 159. Arigo Biolaboratories Corp. VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Arigo Biolaboratories Corp. Main Business
Table 161. Arigo Biolaboratories Corp. Latest Developments
Table 162. Assay Genie Basic Information, VEGFA Antibody Manufacturing Base, Sales Area and Its Competitors
Table 163. Assay Genie VEGFA Antibody Product Offered
Table 164. Assay Genie VEGFA Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Assay Genie Main Business
Table 166. Assay Genie Latest Developments
List of Figures
Figure 1. Picture of VEGFA Antibody
Figure 2. VEGFA Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global VEGFA Antibody Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global VEGFA Antibody Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. VEGFA Antibody Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Monoclonal Antibody
Figure 10. Product Picture of Polyclonal Antibody
Figure 11. Global VEGFA Antibody Sales Market Share by Type in 2021
Figure 12. Global VEGFA Antibody Revenue Market Share by Type (2017-2022)
Figure 13. VEGFA Antibody Consumed in Flow Cytometry
Figure 14. Global VEGFA Antibody Market: Flow Cytometry (2017-2022) & (K Units)
Figure 15. VEGFA Antibody Consumed in ELISA
Figure 16. Global VEGFA Antibody Market: ELISA (2017-2022) & (K Units)
Figure 17. VEGFA Antibody Consumed in Western Blot
Figure 18. Global VEGFA Antibody Market: Western Blot (2017-2022) & (K Units)
Figure 19. VEGFA Antibody Consumed in Immunoprecipitation
Figure 20. Global VEGFA Antibody Market: Immunoprecipitation (2017-2022) & (K Units)
Figure 21. VEGFA Antibody Consumed in Immunofluorescence
Figure 22. Global VEGFA Antibody Market: Immunofluorescence (2017-2022) & (K Units)
Figure 23. VEGFA Antibody Consumed in Other
Figure 24. Global VEGFA Antibody Market: Other (2017-2022) & (K Units)
Figure 25. Global VEGFA Antibody Sales Market Share by Application (2017-2022)
Figure 26. Global VEGFA Antibody Revenue Market Share by Application in 2021
Figure 27. VEGFA Antibody Revenue Market by Company in 2021 ($ Million)
Figure 28. Global VEGFA Antibody Revenue Market Share by Company in 2021
Figure 29. Global VEGFA Antibody Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global VEGFA Antibody Revenue Market Share by Geographic Region in 2021
Figure 31. Global VEGFA Antibody Sales Market Share by Region (2017-2022)
Figure 32. Global VEGFA Antibody Revenue Market Share by Country/Region in 2021
Figure 33. Americas VEGFA Antibody Sales 2017-2022 (K Units)
Figure 34. Americas VEGFA Antibody Revenue 2017-2022 ($ Millions)
Figure 35. APAC VEGFA Antibody Sales 2017-2022 (K Units)
Figure 36. APAC VEGFA Antibody Revenue 2017-2022 ($ Millions)
Figure 37. Europe VEGFA Antibody Sales 2017-2022 (K Units)
Figure 38. Europe VEGFA Antibody Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa VEGFA Antibody Sales 2017-2022 (K Units)
Figure 40. Middle East & Africa VEGFA Antibody Revenue 2017-2022 ($ Millions)
Figure 41. Americas VEGFA Antibody Sales Market Share by Country in 2021
Figure 42. Americas VEGFA Antibody Revenue Market Share by Country in 2021
Figure 43. United States VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC VEGFA Antibody Sales Market Share by Region in 2021
Figure 48. APAC VEGFA Antibody Revenue Market Share by Regions in 2021
Figure 49. China VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 53. India VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe VEGFA Antibody Sales Market Share by Country in 2021
Figure 56. Europe VEGFA Antibody Revenue Market Share by Country in 2021
Figure 57. Germany VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 58. France VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa VEGFA Antibody Sales Market Share by Country in 2021
Figure 63. Middle East & Africa VEGFA Antibody Revenue Market Share by Country in 2021
Figure 64. Egypt VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country VEGFA Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of VEGFA Antibody in 2021
Figure 70. Manufacturing Process Analysis of VEGFA Antibody
Figure 71. Industry Chain Structure of VEGFA Antibody
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ヒストン脱アセチル化酵素1（HDAC1）抗体の世界市場2022-2028：モノクローナル抗体、ポリクローナル抗体
  • 神経栄養受容体チロシンキナーゼ2（NTRK2）抗体の世界市場2022-2028：モノクローナル抗体、ポリクローナル抗体
  • マイトジェン活性化プロテインキナーゼキナーゼ1（MEK1）抗体の世界市場2022-2028：モノクローナル抗体、ポリクローナル抗体
  • プロスタグランジン-エンドペルオキシド合成酵素2（COX-2）抗体の世界市場2022-2028：モノクローナル抗体、ポリクローナル抗体
  • 癌胎児性抗原関連細胞接着分子5 （CEACAM5） 抗体の世界市場2022-2028：モノクローナル抗体、ポリクローナル抗体
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(LP22DC5060 )"VEGFA 抗体の世界市場2022-2028：モノクローナル抗体、ポリクローナル抗体" (英文：Global VEGFA Antibody Market Growth 2022-2028)はLP Information社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。